Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jul 29, 2024
Date Accepted: Jul 1, 2025

The final, peer-reviewed published version of this preprint can be found here:

Digital Tools for People Without an Alzheimer Disease or Dementia Diagnosis: Scoping Review

de Rijke TJ, Engelsma T, Ng CH, Kaijser KK, Nap HH, Smets EM, Visser LN

Digital Tools for People Without an Alzheimer Disease or Dementia Diagnosis: Scoping Review

J Med Internet Res 2025;27:e64862

DOI: 10.2196/64862

PMID: 40854181

PMCID: 12377699

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Digital tools for people in pre-dementia stages: a scoping review

  • Tanja J. de Rijke; 
  • Thomas Engelsma; 
  • Chi Him Ng; 
  • Kyra K.M. Kaijser; 
  • Henk Herman Nap; 
  • Ellen M.A. Smets; 
  • Leonie N.C. Visser

ABSTRACT

Background:

The field of Alzheimer’s disease (AD) moves towards earlier diagnoses in pre-dementia stages, personalized prognosis, and dementia prevention. In the near future, a gap is expected between the growing demand for Alzheimer-related healthcare and a shrinking workforce. Responsibility is increasingly assigned to individuals to take an active role in their own brain health. Digital tools are thought to offer support with regard to these processes.

Objective:

The aim of this scoping review is to create an overview of digital tools published in scientific literature in the context of Alzheimer’s disease and dementia, with cognitively unimpaired people and/or people in pre-dementia stages as primary end-users interacting with these digital tools. Additionally, we aim to gain insight into study sample diversity, the stage of maturity and evaluation of these tools, and recommended future directions.

Methods:

PubMed, IEEE Xplore, Ovid, and Web of Science were searched in January 2023, using terms on Alzheimer’s disease and dementia, (pre-)disease stages, digital tools, and purposes of digital tools. Two independent reviewers screened 2811 records on title and abstract, and subsequently 408 full text articles, based on in- and exclusion criteria. Articles on tools targeting those with an Alzheimer’s disease or dementia diagnosis were excluded. Data extraction included information on the sample characteristics, the digital tool, stage of maturity and evaluation, and future (research) directions.

Results:

We included 39 articles, which were aimed at primary prevention (15/39; 38.5%), secondary prevention (10/39;25.6%), daily life support (8/39; 20.5%), diagnosis and risk assessment (4/39;10.3%), or decision-making (2/39; 5.1%). Variation in study sample emerged regarding cognitive abilities (healthy (11/39; 28.2%); mild cognitive impairment (11/39; 28.2%), (subjective) cognitive impairment (10/39; 25.6%); ‘no dementia’ (1/39; 2.6%), and variation of cognitive abilities (6/39; 15.4%)). Less variation was found regarding sex (>50% female: 27/39; 69.2%), education ( >50% high education: 13/39; 33.3%), and age (>50% >60 years: 23/39; 59%). Few articles reported on ethnicity (12/39; 30.7%) and digital literacy (11/39; 28.2%). Most tools were in an early evaluation and maturity stage (31/39; 79.5%), comprising pre-prototyping (1/35; 2.9%), prototyping (15/35; 42.9%), pilot testing (19/35; 54.3%), efficacy testing (18/40; 45%), usability testing (12/40; 30%), and feasibility testing (10/40; 25%). Future (research) directions comprise the need for further tool development, attention to diversity, and study advancements, such as large-scale longitudinal studies.

Conclusions:

79.5% of tools as reported on in academic literature are considered to be in an early maturity stage. Studies and evidence gathered for digital tools for people (at risk) in pre-dementia stages is thus preliminary and further developments and research is needed before these tools can be implemented for assessing, supporting and preventing cognitive decline.


 Citation

Please cite as:

de Rijke TJ, Engelsma T, Ng CH, Kaijser KK, Nap HH, Smets EM, Visser LN

Digital Tools for People Without an Alzheimer Disease or Dementia Diagnosis: Scoping Review

J Med Internet Res 2025;27:e64862

DOI: 10.2196/64862

PMID: 40854181

PMCID: 12377699

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.